Background: While simultaneous saccharification and co-fermentation (SSCF) is considered to be a promising process for bioconversion of lignocellulosic materials to ethanol, there are still relatively little demo-plant data and operating experiences reported in the literature. In the current work, we designed a SSCF process and scaled up from lab to demo scale reaching 4% (w/v) ethanol using xylose rich corncobs.

Results: Seven different recombinant xylose utilizing Saccharomyces cerevisiae strains were evaluated for their fermentation performance in hydrolysates of steam pretreated corncobs. Two strains, RHD-15 and KE6-12 with highest ethanol yield and lowest xylitol yield, respectively were further screened in SSCF using the whole slurry from pretreatment. Similar ethanol yields were reached with both strains, however, KE6-12 was chosen as the preferred strain since it produced 26% lower xylitol from consumed xylose compared to RHD-15. Model SSCF experiments with glucose or hydrolysate feed in combination with prefermentation resulted in 79% of xylose consumption and more than 75% of the theoretical ethanol yield on available glucose and xylose in lab and PDU scales. The results suggest that for an efficient xylose conversion to ethanol controlled release of glucose from enzymatic hydrolysis and low levels of glucose concentration must be maintained throughout the SSCF. Fed-batch SSCF in PDU with addition of enzymes at three different time points facilitated controlled release of glucose and hence co-consumption of glucose and xylose was observed yielding 76% of the theoretical ethanol yield on available glucose and xylose at 7.9% water insoluble solids (WIS). With a fed-batch SSCF in combination with prefermentation and a feed of substrate and enzymes 47 and 40 g l-1 of ethanol corresponding to 68% and 58% of the theoretical ethanol yield on available glucose and xylose were produced at 10.5% WIS in PDU and demo scale, respectively. The strain KE6-12 was able to completely consume xylose within 76 h during the fermentation of hydrolysate in a 10 m3 demo scale bioreactor.

Conclusions: The potential of SSCF is improved in combination with prefermentation and a feed of substrate and enzymes. It was possible to successfully reproduce the fed-batch SSCF at demo scale producing 4% (w/v) ethanol which is the minimum economical requirement for efficient lignocellulosic bioethanol production process.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598390PMC
http://dx.doi.org/10.1186/1754-6834-6-2DOI Listing

Publication Analysis

Top Keywords

demo scale
16
ethanol yield
16
glucose xylose
16
combination prefermentation
12
theoretical ethanol
12
yield glucose
12
fed-batch sscf
12
ethanol
10
xylose
10
sscf
9

Similar Publications

Backgrounds: Dissociative experiences are described as crucial psychological mechanisms involving the organism's responses to severe psychological traumas and unpleasant past experiences. This research was conducted to examine the psychometric properties of the Dissociative Experiences Measure, Oxford (DEMO) in the Iranian general population.

Methods: This study used cross-sectional correlation, and the statistical population consisted of Iranians over 15 years old.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the importance of occupational well-being for employees at Abadan University of Medical Sciences, considering their roles in healthcare and education.
  • Two hundred employees participated in the research, which utilized a well-being scale and Smart-PLS software for data analysis to develop and test a model of occupational well-being.
  • Results indicate a strong fit for the well-being measurement model, with high reliability, suggesting it could be useful for future research on employee wellness.
View Article and Find Full Text PDF

Accurate counting of cereals crops, e.g., maize, rice, sorghum, and wheat, is crucial for estimating grain production and ensuring food security.

View Article and Find Full Text PDF

Beneficial Impact of Vaccination Against SARS-CoV-2 on the Mental Health of IPF Patients.

Adv Respir Med

November 2024

2nd Pulmonary Medicine Department, General University Hospital "Attikon", Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.

Article Synopsis
  • Depression and anxiety are common issues for patients with idiopathic pulmonary fibrosis (IPF), negatively impacting their quality of life, especially during the COVID-19 pandemic.
  • A study aimed to evaluate how COVID-19 vaccination affects these mental health issues in IPF patients, using the Hospital Anxiety and Depression Scale (HADS) to measure changes before and after vaccination.
  • Results showed a significant improvement in both anxiety and depression scores one month after vaccination, indicating that the vaccine may have beneficial effects on mental health for IPF patients, regardless of factors like age or previous mental health history.
View Article and Find Full Text PDF

Identifying the frequencies of drug-side effects is crucial for assessing drug risk-benefit. However, accurately determining these frequencies remains challenging due to the limitations of time and scale in clinical randomized controlled trials. As a result, several computational methods have been proposed to address these issues.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!